Monica Bocchia

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

Francesco Passamonti, Chiara Cattaneo, Luca Arcaini et al. · The Lancet Haematology · 2020 · 554 citations · Full text

Medicine, Hematology, Oncology +16

Specific human cellular immunity to bcr-abl oncogene-derived peptides

Monica Bocchia, Tatyana Korontsvit, Qin Xu et al. · Blood · 1996 · 290 citations

Life Sciences, Immunology, Molecular Biology +9

Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia

Francesco Zaja, Michele Baccarani, Patrizio Mazza et al. · Blood · 2010 · 259 citations

Life Sciences, Immunology, Pharmacotherapy +7

Vaccination of patients with chronic myelogenous leukemia with bcr-abl oncogene breakpoint fusion peptides generates specific immune responses

Javier Pinilla‐Ibarz, Kathleen N. S. Cathcart, Tatyana Korontsvit et al. · Blood · 2000 · 248 citations

Medicine, Immunology, Oncology +13

Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia

Robert J. Kreitman, Claire Dearden, Pier Luigi Zinzani et al. · Leukemia · 2018 · 247 citations · Full text

Medicine, Oncology, Pharmacology +16